Sio Capital Management as of June 30, 2022
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 61 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AmerisourceBergen (COR) | 9.7 | $26M | 183k | 141.48 | |
| Medicus Sciences Acquisition Cl A Shs | 8.5 | $23M | 2.3M | 9.78 | |
| Organon & Co Common Stock (OGN) | 7.3 | $19M | 575k | 33.75 | |
| Cigna Corp (CI) | 5.2 | $14M | 53k | 263.53 | |
| Inogen (INGN) | 4.8 | $13M | 525k | 24.18 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 4.3 | $12M | 689k | 16.78 | |
| Centene Corporation (CNC) | 4.1 | $11M | 129k | 84.61 | |
| Hca Holdings (HCA) | 3.9 | $10M | 62k | 168.06 | |
| United Therapeutics Corporation (UTHR) | 3.5 | $9.4M | 40k | 235.64 | |
| Bausch Health Companies (BHC) | 3.3 | $8.8M | 1.0M | 8.36 | |
| Inari Medical Ord (NARI) | 2.9 | $7.6M | 113k | 67.99 | |
| Biogen Idec (BIIB) | 2.7 | $7.3M | 36k | 203.93 | |
| Medtronic SHS (MDT) | 2.7 | $7.2M | 80k | 89.75 | |
| Sight Sciences (SGHT) | 2.4 | $6.5M | 725k | 8.99 | |
| Natus Medical | 2.4 | $6.3M | 191k | 32.77 | |
| Cardinal Health (CAH) | 2.3 | $6.2M | 119k | 52.27 | |
| Tenet Healthcare Corp Com New (THC) | 2.1 | $5.5M | 105k | 52.56 | |
| Vanda Pharmaceuticals (VNDA) | 2.0 | $5.3M | 489k | 10.90 | |
| Biohaven Pharmaceutical Holding | 1.9 | $5.1M | 35k | 145.71 | |
| The Beauty Health Company Com Cl A (SKIN) | 1.7 | $4.7M | 362k | 12.86 | |
| Inhibrx | 1.6 | $4.1M | 365k | 11.35 | |
| Universal Health Services CL B (UHS) | 1.5 | $4.1M | 41k | 100.70 | |
| Heska Corp Com Restrc New | 1.4 | $3.7M | 40k | 94.50 | |
| Point Biopharma Global | 1.3 | $3.4M | 505k | 6.81 | |
| Horizon Therapeutics Pub L SHS | 1.2 | $3.2M | 40k | 79.75 | |
| Modular Medical Com New (MODD) | 1.1 | $3.0M | 574k | 5.18 | |
| Viking Therapeutics (VKTX) | 1.1 | $2.9M | 1000k | 2.89 | |
| Prometheus Biosciences Put Option | 1.1 | $2.9M | 102k | 28.23 | |
| Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.9 | $2.5M | 249k | 10.02 | |
| Health Sciences Acquisitions Corp 2 Ord Shs | 0.9 | $2.5M | 250k | 9.96 | |
| Aeglea Biotherapeutics | 0.9 | $2.4M | 4.7M | 0.51 | |
| Affimed Therapeutics B V | 0.9 | $2.3M | 821k | 2.77 | |
| Merus N V (MRUS) | 0.7 | $2.0M | 88k | 22.64 | |
| Cymabay Therapeutics | 0.6 | $1.6M | 556k | 2.95 | |
| Precision Biosciences Ord | 0.6 | $1.6M | 1.0M | 1.60 | |
| Moleculin Biotech | 0.6 | $1.5M | 1.0M | 1.45 | |
| Renovacor | 0.6 | $1.5M | 736k | 2.03 | |
| Savara (SVRA) | 0.5 | $1.3M | 856k | 1.52 | |
| Biosante Pharmaceuticals (ANIP) | 0.4 | $1.2M | 40k | 29.68 | |
| Albireo Pharma | 0.4 | $1.2M | 59k | 19.86 | |
| Tyra Biosciences (TYRA) | 0.4 | $1.1M | 152k | 7.15 | |
| Pardes Biosciences | 0.4 | $969k | 316k | 3.07 | |
| Neubase Therapeutics Ord | 0.4 | $952k | 906k | 1.05 | |
| Isoplexis Corp | 0.3 | $879k | 407k | 2.16 | |
| Iveric Bio Put Option | 0.3 | $831k | 86k | 9.62 | |
| Fusion Pharmaceuticals | 0.2 | $649k | 260k | 2.49 | |
| Aslan Pharmaceuticals Ads | 0.2 | $629k | 1.3M | 0.49 | |
| Nextcure (NXTC) | 0.2 | $611k | 130k | 4.70 | |
| Connect Biopharma Holdings Ads (CNTB) | 0.2 | $520k | 598k | 0.87 | |
| Elevation Oncology (ELEV) | 0.2 | $504k | 360k | 1.40 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $498k | 16k | 30.43 | |
| Cyclacel Pharmaceuticals | 0.2 | $491k | 454k | 1.08 | |
| Ardelyx (ARDX) | 0.2 | $408k | 692k | 0.59 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $267k | 277k | 0.96 | |
| Nyxoah Sa SHS (NYXH) | 0.1 | $148k | 16k | 9.19 | |
| Vincerx Pharma Com New (VINC) | 0.1 | $135k | 102k | 1.32 | |
| Caremax Com Cl A | 0.0 | $112k | 31k | 3.64 | |
| Humacyte *w Exp 09/21/202 (HUMAW) | 0.0 | $45k | 50k | 0.90 | |
| Neoleukin Therapeutics | 0.0 | $39k | 38k | 1.02 | |
| Renovacor *w Exp 99/99/999 | 0.0 | $34k | 400k | 0.09 | |
| Caremax *w Exp 06/08/2026 | 0.0 | $9.0k | 13k | 0.70 |
